Prelude Therapeutics Inc
SEC CIK 1678660 · PRLD · last insider filing 2026-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baker Julian | Director | filed 2020 - 2026 |
| Baker Felix | Director | filed 2020 - 2026 |
| Friedman Paul A | Director | filed 2020 - 2026 |
| Baker Bros. Advisors LP | Director | filed 2020 - 2026 |
| Baker Brothers Life Sciences LP | Director | filed 2020 - 2026 |
| Babler Martin | Director | filed 2021 - 2026 |
| 667, L.P. | Director | filed 2020 - 2026 |
| Bonita David P | Director | filed 2020 - 2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2020 - 2026 |
| Dorton Katina | Director | filed 2025 - 2026 |
| Sandor Victor | Director | filed 2020 - 2026 |
| Orbimed Advisors LLC | Director | filed 2020 - 2026 |
| Orbimed Capital LLC | Director | filed 2020 - 2026 |
| Orbimed Capital GP VI LLC | Director | filed 2020 - 2026 |
| Orbimed Genesis GP LLC | Director | filed 2026 - 2026 |
| Vaddi Krishna | Director · President, CEO | filed 2020 - 2026 |
| Dier Mardi | Director | filed 2020 - 2025 |
| Scherer Paul C | Director | filed 2025 - 2025 |
| Neu Kelvin | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Morris Charles Q | Chief Medical Officer | filed 2026 - 2026 |
| Brusky Sean P. | Chief Business Officer | filed 2026 - 2026 |
| Lim Bryant David | Chief Legal Officer, Corp Sec. | filed 2023 - 2026 |
| Scherle Peggy | Chief Scientific Officer | filed 2020 - 2026 |
| Combs Andrew | EVP, Head of Chemistry | filed 2020 - 2026 |
| Huang Jane | President, CMO | filed 2022 - 2025 |
| Chardonnet Laurent | Chief Financial Officer | filed 2021 - 2024 |
| Morosini Deborah | EVP, Chief of Clinical Affairs | filed 2020 - 2022 |
| Mauro David J | Chief Medical Officer | filed 2020 - 2021 |
| Pierce Christopher | EVP and Chief of Business Oper | filed 2020 - 2021 |
| Piper Brian | Chief Financial Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.